Discover the causes behind fatty liver disease, a condition affecting 25% of adults worldwide, and learn simple lifestyle ...

Researchers have developed an advanced model that facilitates the study of drug metabolism during pregnancy by ...

Metabolic Associated Fatty Liver Disease (MAFLD) has emerged as a global public health concern due to its increasing ...

Maintaining optimal digestive health is crucial for overall well-being in today's fast-paced world. Many individuals struggle ...

Researchers at the Garvan Institute of Medical Research have uncovered how pancreatic cancer hijacks a crucial metabolism ...

The company plans to resume its CATT1 Phase 3 trial for type 1 diabetes after submitting a protocol amendment.

liver failure or cancer. Currently, there is no approved drug that can stop the disease from getting worse, making it a major health concern. A recent study published on January 31, 2024 ...

Ready to save your liver? Transcription factors are paving the way for metabolic dysfunction-associated fatty liver disease ...

Tv Therapeutics' Phase 3 trial for cadisegliatin in type 1 diabetes resumes after FDA lifts hold, with a revised six-month ...

Cadisegliatin has the potential to be the first oral adjunct therapy for type 1 diabetes CATT1 Phase 3 trial expected to ...

Anyone who has tried to lose weight by cutting calories knows the frustration—after initial success, weight loss slows down ...

Tv Therapeutics (VTVT) announced that the United States Food and Drug Administration has lifted the clinical hold on the cadisegliatin ...